Clininco - pathological study of medullary thyroid carcinoma in NCI / Mohamed Mostafa Ragab Ali Shalaby ; Supervised Hatem Ahmed Aboulkassem , Omar Zakaria Youssef , Neveen Samir Tahoun
Material type: TextLanguage: English Publication details: Cairo : Mohamed Mostafa Ragab Ali Shalaby , 2014Description: 131 P. : facsimiles ; 25cmOther title:- الأورام السرطانية للغدة الدرقية فى المعهد القومى للأورام : دراسة باثولوجية اكلينيكية [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|---|
Thesis | قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.19.04.M.Sc.2014.Mo.C (Browse shelf(Opens below)) | Not for loan | 01010110064295000 | |||
CD - Rom | مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.19.04.M.Sc.2014.Mo.C (Browse shelf(Opens below)) | 64295.CD | Not for loan | 01020110064295000 |
Thesis (M.Sc.) - Cairo University - National Cancer Institute - Department of Oncology - Surgical
Medullary thyroid carcinoma (MTC) is a rare malignancy with several distinctive features that distinguish its management from other thyroid cancers. First, MTC may be sporadic (75% of cases), or may occur as a manifestation of the hereditary syndrome multiple endocrine Neoplasia type 2 (MEN 2) (25% of cases). We studied 30 patients with known MTC who were treated in NCI in the period from 2000 to 2012. The results were similar to other studies that had done around the world. 14 patients were males, mean age was 45 years,19 patients were in stage IVA,10 year overall survival (OS) 56%, in NCI we have a defect in diagnosis of familial MTC because we don{u2019}t conduct genetic testing on suspected patients we also don{u2019}t do neither pr- nor post- operative calcitonin test as a tumour marker during follow up
Issued also as CD
There are no comments on this title.